BTV-Business Television explores the burgeoning sector that has captured the attention of investors.
Entheon Biomedical Corp. (CSE: ENBI, OTCQB: ENTBF)
Researching and developing DMT, one of the most powerful of its kind in existence, to address substance use disorders related to nicotine, alcohol, and more. Elemer Piros, Analyst at Roth Capital Partners, weighs in.
Psyched Wellness Ltd. (CSE: PSYC, OTCQB: PSYCF)
BTV reports on their pre-clinical studies underway with a proprietary extract from the poisonous Amanita Muscaria mushroom. Psyched Wellness was created with the purpose of benefitting the health of people, plants and the planet.
Small Pharma Inc. (TSX.V: DMT)
BTV learns about DMT, the subject of a Small Pharma clinical trial dealing with depression – the world’s first. Small Pharma initiated a clinical program into DMT-assisted therapy in February 2021.
Numinus Wellness Inc. (TSX.V: NUMI)
BTV checks in with a company at the forefront of a new and innovative mental health treatment. The company is looking to transform the mental health landscape.
Mydecine Innovations Group (NEO: MYCO, OTC: MYCOF)
BTV discovers how this company is developing treatments to better address the effects of addiction and post-traumatic stress disorder.
On air for over 20 years, BTV – Business Television, a half-hour investment TV show, features analysts and emerging publicly traded companies at their location. With Hosts, Taylor Thoen and Jessica Katrichak, BTV provides viewers with investment opportunities.
TV BROADCAST NETWORKS and TIMES:
US National TV:
Biz Television Network – Sun Aug 1 @ 8:30am EST
Suggest a Company to Feature!
Contact: (604) 664-7401 x3 firstname.lastname@example.org
For more information:
Subscribe to receive more investment opportunities videos:
Check out more videos:
BTV Business Television episodes:
New Listing Alert:
#MentalHealth #Mushrooms #DMT